Results 101 to 110 of about 62,513 (217)

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Structural basis and functional analysis of NMDA receptor regulation by calmodulin. [PDF]

J Biol Chem
Bej A, Erickson-Oberg MQ, Nigam A, Yu I, Hell JW, Johnson JW, Ames JB.   +6 more
europepmc   +1 more source

Pediatric N-methyl-d-aspartate receptor autoimmune encephalitis

Journal of Pediatric Neurosciences, 2018
openaire   +2 more sources

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Glioblastoma mimicking anti-NMDA receptor encephalitis: a case series. [PDF]

Intern Med J
Chatterton S, Jia FF, Clarke AJ, Satgunaseelan L, Soh HC, Ng K, Parratt K, Parratt J.   +7 more
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

A comprehensive review of the clinical progress of esketamine: From anesthesia to antidepressant therapy. [PDF]

Medicine (Baltimore)
Hu HL, Huang QZ, Xie PX.
europepmc   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

British Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown, Alan Armstrong, David J. Mann   +2 more
wiley   +1 more source

Autoimmune Encephalitis Masquerading As Acute Psychosis: A Cause of Delayed Treatment. [PDF]

Cureus
Sharma M, Rallabandi S, Sharma A, Kashyap R.   +3 more
europepmc   +1 more source

N-Methyl-D-Aspartate (NMDA) Receptors [PDF]

, 2011
openaire   +1 more source